Alfi Dog gyógynövényes-kamillás kutyasampon Hungaria - Hungaria - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

alfi dog gyógynövényes-kamillás kutyasampon

vegy-pack 2020 vegyipari kft. - nátrium-klorid, nátrium-lauril-szulfát, citromsav, ioncserélt víz, nátrium-lauril-szulfát / kokamide dea / glikol-sztearát, kokamide dea, kamilla kivonat, kamilla illat, kokamidopropil betain, propilén-glikol / benzil alkohol / metilkloroizotiazolinon / metilizot - sampon - kutya

Alfi Dog kölyökkutya sampon Hungaria - Hungaria - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

alfi dog kölyökkutya sampon

vegy-pack 2020 vegyipari kft. - nátrium-klorid, nátrium-lauril-szulfát, e-vitamin, citromsav, ioncserélt víz, nátrium-lauril-szulfát / kokamide dea / glikol-sztearát, kokamide dea, kamilla kivonat, vadvirág illat, kokamidopropil betain, propilén-glikol / benzil alkohol / metilkloroizotiazolinon / metilizot - sampon - kutya

Kymriah Uni Eropa - Hungaria - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - egyéb daganatellenes szerek - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

CircoMax Myco Uni Eropa - Hungaria - EMA (European Medicines Agency)

circomax myco

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunológiai készítmények suidae számára - sertések (hizlaló) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.